ARDS redux

Clinical Pulmonary Medicine

Volumn 13, Issue 2, 2006, Pages 121-127

  Manthous, Constantine A ^a,b  

^a BRIDGEPORT HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute respiratory distress syndrome; Inflammation; Mechanical ventilation; Respiratory failure

Indexed keywords

ALBUMIN; BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; FUROSEMIDE; NITRIC OXIDE; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; FLUID THERAPY; HUMAN; IATROGENIC DISEASE; INFLAMMATION; PATHOPHYSIOLOGY; RESPIRATORY FAILURE; REVIEW;

EID: 33745676596     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000204205.18610.7a     Document Type: Review

References (64)

1. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress syndrome. Lancet. 1967;7511:319-323.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-824.
3. Artigas A, Bernard GR, Carlet J, et al. The American-European Consensus Conference on ARDS: Part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling: acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1332-1347.
4. Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest. 1999;116(suppl):74-82.
5. Hudson LD, Milberg JA, Anardi D, et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151:293-301.
6. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33:721-726.
7. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44:1774-1789.
8. Sato N, Suzuki Y, Nishio K, et al. Roles of ICAM-1 for abnormal leukocyte recruitment in the microcirculation of bleomycin-induced fibrotic lung injury. Am J Respir Crit Care Med. 2000;161:1681-1688.
9. Welty-Wolf KE, Carraway MS, Huang YC, et al. Antibody to intercellular adhesion molecule 1 (CD54) decreases survival and not lung injury in baboons with sepsis. Am J Respir Crit Care Med. 2001;163:665-673.
10. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Invest Med. 1994;43:640-651.
11. Tomashefski JF. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000;21:435-466.
12. Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med. 2004;141:460-470.
13. Baron RM, Carvajal IM, Fredenburgh LE, et al. Nitric oxide synthase-2 down-regulates surfactant protein-B expression and enhances endotoxin-induced lung injury in mice. FASEB J. 2004;18:1276-1278.
14. Pelosi P, D'Andrea L, Vitale G, et al. Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;149:8-13.
15. Brimioulle S, Julien V, Gust R, et al. Importance of hypoxic pulmonary vasoconstriction in maintaining oxygenation during acute lung injury. Crit Care Med. 2002;30:874-880.
16. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:2149-2150.
17. Ferring M, Vincent JL. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997;10:1297-1300.
18. Leikauf GD, McDowell SA, Wesselkamper SC, et al. Acute lung injury: functional genomics and genetic susceptibility. Chest 2002;121(suppl): 70-75.
19. Marshall RP, Webb S, Hill MR, et al. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest. 2002;121(suppl):68-69.
20. ARDSnet Investigators. Ventilation with lower tidal volumes as compared with traditional tidal volumes for the acute lung injury and the acute respiratory distress syndrome: the Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-1308.
21. Parker JC, Falgout JH, Grimbert FA, et al. The effect of increased vascular pressure on albumin-excluded volume and lymph flow in the dog lung. Circ Res. 1980;47:866-875.
22. Prewitt RM, McCarthy J, Wood LD. Treatment of acute low pressure pulmonary edema in dogs: relative effects of hydrostatic and oncotic pressure, nitroprusside, and positive end-expiratory pressure. J Clin Invest. 1981;67:409-418.
23. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med. 2000;161:1942-1948.
24. Corwin H, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill. Current clinical practice in the United States. Crit Care Med. 2004;32:39-52.
25. Reed CR, Glauser FL. Drug-induced noncardiogenic pulmonary edema: drug-induced noncardiogenic pulmonary edema. Chest. 1991;100:1120-1124.
26. Antonelli M, Conti G, Moro ML, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med. 2001;27: 1718-1728.
27. Gattinoni L, D'Andrea L, Pelosi P, et al. Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA. 1993;269:2122-2127.
28. Corbridge TC, Wood LD, Crawford GP, et al. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis. 1990;142:311-315.
29. Hubmayr RD. Perspective on lung injury and recruitment: a skeptical look at the opening and collapse story. Am J Respir Crit Care Med. 2002;165:1647-1653.
30. Muscadere JG, Mullen JB, Gan K, et al. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994;149:1327-1334.
31. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282: 54-61.
32. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:230-232.
33. Eichacker PQ, Gerstenberger EP, Banks SM, et al. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med. 2002;166:1510-1514.
34. Farias LL, Faffe DS, Xisto DG, et al. Positive end-expiratory pressure prevents lung mechanical stress caused by recruitment/derecruitment. J Appl Physiol. 2005;98:53-61.
35. Brower RG, Lanken PN, Maclntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327-336.
36. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338:347-354.
37. Leatherman JW, Fluegel WL, David WS, et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med. 1996;153:1686-1690.
38. Lang JD, Figueroa M, Sanders KD, et al. Hypercapnia via reduced rate and tidal volume contributes to lipopolysaccharide-induced lung injury. Am J Respir Crit Care Med. 2005;171:147-157.
39. Mantell LL, Horowitz S, Davis JM, et al. Hyperoxia-induced cell death in the lung: the correlation of apoptosis, necrosis, and inflammation. Ann NY Acad Sci. 1999;887:171-180.
40. Santos C, Ferrer M, Roca J, et al. Am J Respir Crit Care Med. 2000;161:26-31.
41. Derdak S, Mehta S, Stewart TE, et al. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med. 2002;166:801-808.
42. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on survival of patients with acute respiratory failure. N Engl J Med. 2001;345:568-573.
43. Barbas CS, deMatos GF, Okamoto V, et al. Lung recruitment maneuvers in acute respiratory distress syndrome. Respir Care Clin North Am. 2003;9:401-418.
44. Lim SC, Adams AB, Simonson DA, et al. Intercomparison of recruitment maneuver efficacy in three models of lung injury. Crit Care Med. 2004;32:2371-2377.
45. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138:494-501.
46. Cash BD. Evidence-based medicine as it applies to acid suppression in the hospitalized patient. Crit Care Med. 2002;30(suppl 6):373-378.
47. Attia J, Ray JB, Cook DJ, et al. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161:1268-1279.
48. Kress JP. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-1477.
49. Van den Berghe G, Wouters P, Weekers F, et al. N Engl J Med. 2001;345: 1359-1367.
50. Mutlu GM, Sznajder JI. Beta(2)-agonists for treatment of pulmonary edema: ready for clinical studies? Crit Care Med. 2004;32:1607-1608.
51. Long R, Breen PH, Mayers I, et al. Treatment of canine aspiration pneumonitis: fluid volume reduction vs. fluid volume expansion. J Appl Physiol. 1988;65:1736-1744.
52. Humphrey H, Hall J, Sznajder I, et al. Improved survival in ARDS patients associated with reduction in capillary wedge pressure. Chest. 1990;97:1176-1180.
53. Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide in hypoproteinemic patients with acute lung injury. Crit Care Med. 2002;30:2175-2182.
54. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005;33:1681-1687.
55. ARDS Network. Prospective, randomized, multi-center trial of pulmonary artery catheter (PAC) vs. central venous catheter (CVC) for management of acute lung injury (ALI) and acute respiratory distress syndrome ARDS. http://www.ardsnet.org/factt.php. Accessed July 6, 2005.
56. Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291:1603-1609.
57. Gunther A, Schmidt R, Feustel A, et al. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates: experimental and clinical studies. Am J Respir Crit Care Med. 1999;159:244-251.
58. Moller JC, Schaible T, Roll C, et al. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 2003;29:437-446.
59. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med. 1996;334:1417-1421.
60. ARDS Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2000;283:1995-2002.
61. ARDS Clinical Trials Network, National Heart, Lung and Blood Institute, National Institutes of Health. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2002;30:1-6.
62. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159-165.
63. ARDS Network. Late steroid rescue study (LASRS): the efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome. http://www.ardsnet.org/lasrs.php. Accessed July 6, 2005.
64. Michard F, Boussat S, Chemla D, et al. Relation between respiratory changes in arterial pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000;162:134-138.